# Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting

> **NCT04898569** · PHASE4 · UNKNOWN · sponsor: **Yonsei University** · enrollment: 100 (estimated)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DRUG:** Ferinject
- **DRUG:** Normal Saline Flush

## Key facts

- **NCT ID:** NCT04898569
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-02-10
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2021-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04898569

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04898569, "Effect of Intravenous Ferric Carboxymaltose on Hemoglobin Response and Transfusion in Patients With Iron Deficiency Anemia After Off-Pump Coronary Artery Bypass Grafting". Retrieved via AI Analytics 2026-05-21 from https://api.ai-analytics.org/clinical/NCT04898569. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*